Missailidis, Sotiris and Hardy, Alison
(2009).
| DOI (Digital Object Identifier) Link: | http://dx.doi.org/doi:10.1517/13543770903042337 |
|---|---|
| Google Scholar: | Look up in Google Scholar |
Abstract
Background: Aptamers as inhibitors of proteins in therapeutic applications offer great advantages over their antibody counterparts and the promise to be developed into the next generation therapeutic agents. However, the control of aptamer intellectual property (IP) by two major players has made aptamers an area difficult to operate and often off-putting for academic and commercial organisations. Yet, their great potential is keeping aptamers at the research forefront, with one aptamer in the clinic and various at different stages of clinical trials. Objective: To provide a comprehensive review of the aptamer IP landscape and the issues associated with aptamer therapeutics against protein targets. Methods: Extensive review of the scientific and patent literature. Conclusions: Following our experience in developing, patenting and commercialising our aptamers against MUC1 and an extensive review of the literature, we have identified a variety of issues pertaining to the development of aptamers against protein targets for therapeutic applications, their patenting and granting of patents, the original IP holders and their policy, as well as the current market and traits. Despite a slow start, aptamers have been developed against various therapeutic proteins and offer the promise of providing a novel generation of therapeutic entities with a variety of applications.
| Item Type: | Journal Article |
|---|---|
| Copyright Holders: | 2009 Informa UK Ltd |
| ISSN: | 1354-3776 |
| Keywords: | aptamers; patents; SELEX; therapeutics |
| Academic Unit/Department: | Science > Life, Health and Chemical Sciences Other Departments > Other Departments |
| Item ID: | 26021 |
| Depositing User: | Sotiris Missailidis |
| Date Deposited: | 12 Jan 2011 11:38 |
| Last Modified: | 23 Oct 2012 14:34 |
| URI: | http://oro.open.ac.uk/id/eprint/26021 |
Actions (login may be required)
| View Item | |
| Public: Report issue / request change |